These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20462470)

  • 1. Swine influenza vaccines: current status and future perspectives.
    Ma W; Richt JA
    Anim Health Res Rev; 2010 Jun; 11(1):81-96. PubMed ID: 20462470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic relationships, serological cross-reaction and cross-protection between H1N2 and other influenza A virus subtypes endemic in European pigs.
    Reeth KV; Brown I; Essen S; Pensaert M
    Virus Res; 2004 Jul; 103(1-2):115-24. PubMed ID: 15163499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against a European H1N2 swine influenza virus in pigs previously infected with H1N1 and/or H3N2 subtypes.
    Van Reeth K; Gregory V; Hay A; Pensaert M
    Vaccine; 2003 Mar; 21(13-14):1375-81. PubMed ID: 12615433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine.
    Richt JA; Lekcharoensuk P; Lager KM; Vincent AL; Loiacono CM; Janke BH; Wu WH; Yoon KJ; Webby RJ; Solórzano A; García-Sastre A
    J Virol; 2006 Nov; 80(22):11009-18. PubMed ID: 16943300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Swine influenza virus: Current status and challenge.
    Ma W
    Virus Res; 2020 Oct; 288():198118. PubMed ID: 32798539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Swine influenza viruses a North American perspective.
    Vincent AL; Ma W; Lager KM; Janke BH; Richt JA
    Adv Virus Res; 2008; 72():127-54. PubMed ID: 19081490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigations of the efficacy of European H1N1- and H3N2-based swine influenza vaccines against the novel H1N2 subtype.
    Van Reeth K; Van Gucht S; Pensaert M
    Vet Rec; 2003 Jul; 153(1):9-13. PubMed ID: 12877210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological profiles after consecutive experimental infections of pigs with European H1N1, H3N2, and H1N2 swine influenza viruses.
    Van Reeth K; Labarque G; Pensaert M
    Viral Immunol; 2006; 19(3):373-82. PubMed ID: 16987057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of guinea pigs by vaccination with a recombinant swinepox virus co-expressing HA1 genes of swine H1N1 and H3N2 influenza viruses.
    Xu J; Yang D; Huang D; Xu J; Liu S; Lin H; Zhu H; Liu B; Lu C
    Arch Virol; 2013 Mar; 158(3):629-37. PubMed ID: 23135159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis and vaccination of influenza A virus in swine.
    Rajao DS; Anderson TK; Gauger PC; Vincent AL
    Curr Top Microbiol Immunol; 2014; 385():307-26. PubMed ID: 25033752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza A virus vaccines for swine.
    Vincent AL; Perez DR; Rajao D; Anderson TK; Abente EJ; Walia RR; Lewis NS
    Vet Microbiol; 2017 Jul; 206():35-44. PubMed ID: 27923501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Swine influenza virus: evolution mechanism and epidemic characterization--a review].
    Qi X; Lu C
    Wei Sheng Wu Xue Bao; 2009 Sep; 49(9):1138-45. PubMed ID: 20030049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccines against influenza A viruses in poultry and swine: Status and future developments.
    Rahn J; Hoffmann D; Harder TC; Beer M
    Vaccine; 2015 May; 33(21):2414-24. PubMed ID: 25835575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of a high-growth reassortant H1N1 influenza virus vaccine against the classical swine H1N1 subtype influenza virus in mice and pigs.
    Wen F; Yu H; Yang FR; Huang M; Yang S; Zhou YJ; Li ZJ; Tong GZ
    Arch Virol; 2014 Nov; 159(11):2957-67. PubMed ID: 24957653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus.
    Wesley RD; Tang M; Lager KM
    Vaccine; 2004 Sep; 22(25-26):3427-34. PubMed ID: 15308368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming maternal antibody interference by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of swine influenza virus.
    Wesley RD; Lager KM
    Vet Microbiol; 2006 Nov; 118(1-2):67-75. PubMed ID: 16939702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine.
    Vincent AL; Lager KM; Janke BH; Gramer MR; Richt JA
    Vet Microbiol; 2008 Jan; 126(4):310-23. PubMed ID: 17719188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine development for protecting swine against influenza virus.
    Chen Q; Madson D; Miller CL; Harris DL
    Anim Health Res Rev; 2012 Dec; 13(2):181-95. PubMed ID: 23253165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and protective efficacy of an elastase-dependent live attenuated swine influenza virus vaccine administered intranasally in pigs.
    Masic A; Lu X; Li J; Mutwiri GK; Babiuk LA; Brown EG; Zhou Y
    Vaccine; 2010 Oct; 28(43):7098-108. PubMed ID: 20708697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral Fluids as a Live-Animal Sample Source for Evaluating Cross-Reactivity and Cross-Protection following Intranasal Influenza A Virus Vaccination in Pigs.
    Hughes HR; Vincent AL; Brockmeier SL; Gauger PC; Pena L; Santos J; Braucher DR; Perez DR; Loving CL
    Clin Vaccine Immunol; 2015 Oct; 22(10):1109-20. PubMed ID: 26291090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.